Literature DB >> 23445196

Immunopathogenesis of allergic disorders: current concepts.

Yashwant Kumar1, Alka Bhatia.   

Abstract

Allergic disorders are a group of immune-mediated disorders that are associated with considerable morbidity and ill health. There has been significant rise in the prevalence of allergy in the last few years. This has heightened interest in uncovering the novel mechanisms involved in etiopathogenesis of allergic disorders. Understanding the pathways underlying allergy will help in developing effective modalities for its prevention and treatment. This review focuses primarily on common IgE-mediated allergic conditions and recent developments in their immunopathogenesis, especially those involving respiratory mucosa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23445196     DOI: 10.1586/eci.12.104

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  4 in total

1.  The prevalence of allergic diseases in school children of metropolitan city in Indonesia shows a similar pattern to that of developed countries.

Authors:  Gatot Soegiarto; Mai Shihah Abdullah; Luki Agustina Damayanti; Arief Suseno; Chaerul Effendi
Journal:  Asia Pac Allergy       Date:  2019-04-20

2.  Amelioration of Ovalbumin-Induced Allergic Asthma by Juglans regia via Downregulation of Inflammatory Cytokines and Upregulation of Aquaporin-1 and Aquaporin-5 in Mice.

Authors:  Mariam Sharif; Irfan Anjum; Arham Shabbir; Shahzada Khurram Syed; Iqra Mobeen; Muhammad Hassaan Shahid; Kamran Sarwar
Journal:  J Trop Med       Date:  2022-03-30

3.  α-Linolenic Acid Screened by Molecular Docking Attenuates Inflammation by Regulating Th1/Th2 Imbalance in Ovalbumin-Induced Mice of Allergic Rhinitis.

Authors:  Mengyue Ren; Yi Wang; Lin Lin; Shaoqiang Li; Qinhai Ma
Journal:  Molecules       Date:  2022-09-11       Impact factor: 4.927

Review 4.  Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.

Authors:  Xue Yan Wang; Margaret Lim-Jurado; Narayanan Prepageran; Pongsakorn Tantilipikorn; De Yun Wang
Journal:  Ther Clin Risk Manag       Date:  2016-04-13       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.